Skin Proteomic Analysis of Immune Activation Associated with Regression of Melanoma Metastases Induced by Diphencyprone

Published: 17 August 2022| Version 1 | DOI: 10.17632/f5ttw4mygy.1
Contributors:
Joseph Han,
Joel Correa da Rosa,
Shayan Owji,
Daniel Yassky,
Yen Luu,
Yeriel Estrada,
Jonathan Ungar,
Andrew Ji,
James G Krueger,
Nicholas Gulati

Description

Supplementary Data for Skin Proteomic Analysis of Immune Activation Associated with Regression of Melanoma Metastases Induced by Diphencyprone

Files

Institutions

Icahn School of Medicine at Mount Sinai

Categories

Proteomics, Biomarkers, Clinical Trial, Diphencyprone, Metastasis, Melanoma

License